Dr Reddy's Laboratories planning to launch value-added drugs in US

08 Jul 2019 Evaluate

Dr Reddy's Laboratories is planning to launch several value-added products this fiscal in the US market to offset the persisting problem. Moreover, the company is also planning to re-focus some of its Research and Development resources to service the high potential branded generics markets such as China, Russia and other emerging markets. As many as 110 generic filings awaiting approval from the USFDA and the company has to leverage this and ensure that they succeed in delivering these products, molecule by molecule, to the US on the due dates.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1155.50 -11.40 (-0.98%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×